CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 8-K Event Executive or director change
- 10-K/A Report 10-K/A
- 424B3 Offering Prospectus
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 424B3 Offering Prospectus
Page 4 of 13 · 258 filings